Arzeda
Arzeda designs novel proteins and enzymes using AI-driven computational methods, delivering BioSolutions for industries such as food and nutrition, home and personal care, advanced materials, and pharmaceuticals. Its products aim to improve customer products and manufacturing processes while reducing environmental impact.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology Research
- Founded
- 2009 Seattle business license
- Type
- Corporation Seattle business license
- Employees
- 79
- Registered name
- Arzeda Corp Seattle business license
- Members see funding amounts. .
- Founders
- Alexandre Zanghellini, David Baker
Is this your organization? Claim it
Arzeda tells National Security Commission U.S. biotech lacks domestic manufacturing, risking commercial scale‑up to overseas partners
Arzeda, a Seattle enzyme-design startup that reaches about 1.8 billion consumers, says U.S. biotech companies have strong science but lack domestic manufacturing capacity and workforce, forcing them to rely on Western Europe and India; the National Security Commission on Emerging Biotechnology visited to hear calls for investment and infrastructure to keep production stateside.
MANE secures exclusive global license from Arzeda to produce and commercialize ViaLeaf™ Reb M, enabling end-to-end Reb M value chain
MANE secured an exclusive global license from Arzeda to produce and commercialize ViaLeaf™ Reb M, combining Arzeda’s AI-driven protein design with MANE’s manufacturing and commercial capabilities to scale a cost-effective, high-quality sugar-reduction ingredient worldwide.
Arzeda and KENT Specialty Milling Forge Product Development Agreement to Combine AI Protein Design with Manufacturing Scale
Arzeda and KENT Specialty Milling have entered a product development agreement to combine Arzeda’s AI-driven Intelligent Protein Design Technology with KENT’s manufacturing scale and market expertise to develop customer-focused protein solutions. The partnership aims to design and validate novel proteins to improve performance and efficiency across relevant end markets, though technical details and milestones remain undisclosed.
Arzeda and MANE partner to commercialize ViaLeaf™ Reb M with >500 t/year cell-free production of 95%‑pure steviol glycoside
Arzeda is partnering with flavor company MANE to commercialize ViaLeaf™ Reb M, a high-purity steviol glycoside produced via cell-free reactions with >500 metric tons/year capacity and reduced bitterness versus Reb A.
MANE and Arzeda partner to commercialize ViaLeaf™ Reb M, scaling AI-designed direct-from-leaf stevia for cost-effective, clean-label sugar reduction
MANE and Arzeda have formed a strategic partnership to commercialize ViaLeaf™ Reb M, combining Arzeda’s AI-driven enzyme design with MANE’s global flavor and production capabilities to scale a direct-from-leaf stevia extract that aims to deliver cost-effective, clean-label sugar reduction without sacrificing taste.
Arzeda to lead $7.8M NSF CFIRE consortium with Missouri S&T and Novonesis to develop AI-designed electricity-driven enzyme cascades
Arzeda will lead a $7.8M NSF CFIRE consortium with Missouri S&T and Novonesis to develop AI-designed, electricity-powered enzyme cascades aimed at >70% energy efficiency and CO₂-to-methanol conversion for sustainable chemical production.
Arzeda to Lead ~$6.3M NSF USPRD Consortium with Stanford, UNC, UC Irvine and UC Davis to Scale Cell-Free Biomanufacturing via AI-Designed Enzymes
Arzeda will lead an approximately $6.3M NSF USPRD consortium with Stanford, UNC Chapel Hill, UC Irvine, and UC Davis to scale industrial cell-free biomanufacturing using AI-designed enzymes that function with low-cost non‑natural cofactors, aiming to expand economically viable products from bio-based materials to specialty chemicals.
Arzeda Doubles ProSweet Reb M™ Stevia Capacity to 500 MT/Year with New U.S. Production, Now Producing on Two Continents
Arzeda has doubled production of its ProSweet Reb M™ stevia to 500 metric tons per year by adding U.S. capacity, now manufacturing on two continents to ensure reliable supply for North American food and beverage customers.
Arzeda Expands ProSweet Reb M™ Stevia Production into Europe, Raising Capacity Above 250 MT/Year to Replace ~75,000 Tons of Sugar
Arzeda has expanded production of its ProSweet Reb M™ stevia into Europe, raising capacity to over 250 metric tons per year—enough to replace about 75,000 tons of sugar annually—to meet rising demand from CPG companies for a lower-cost, great-tasting natural sweetener.
Arzeda Wins DARPA BTO Award to Advance AI Protein Design Using Limited Data for National Security
Arzeda received DARPA BTO funding to expand its AI-driven protein design platform, aiming to design and validate novel proteins from limited training data for national-security, health, and manufacturing applications.
Arzeda, Co-founded by Nobel Laureate David Baker, Produces 10+ Tons of ProSweet RebM™ Stevia, Claims Equivalent of Replacing 3,000 Tons of Sugar
Arzeda, co-founded by Nobel laureate David Baker, has surpassed 10 tons of ProSweet RebM™ stevia production—enough to replace 3,000 tons of sugar—and scaled its team to over 70 employees across ML, protein testing, strain design, and operations. The company says it brought ProSweet RebM™ to market in one-third the usual time and is expanding production to meet global demand.
Arzeda Raises $38M Oversubscribed Round from Sofinnova, Fall Line, Sucden, Silver Blue and W.L. Gore to Scale ProSweet and Commercialize Designer Proteins
Arzeda raised $38M in an oversubscribed round led by new investors including Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and W.L. Gore’s venture arm to scale ProSweet stevia enzyme production and speed commercialization of additional designer proteins.
Arzeda and W. L. Gore & Associates Sign Joint Development Agreement to Use Intelligent Protein Design for Sustainable Materials
Arzeda and W. L. Gore & Associates have expanded a successful collaboration into a joint development agreement to apply Arzeda’s Intelligent Protein Design Technology™ to create novel, sustainable materials with improved performance.
Unilever and Arzeda use AI-driven protein design to create low-temperature stain-fighting enzymes in 18 months, cutting ingredients and carbon footprint
Unilever and synthetic biology firm Arzeda used AI-driven protein design to create low-temperature, higher-stability stain-fighting enzymes in 18 months — five times faster than before — that could halve required ingredients and reduce the carbon footprint of Unilever’s Home Care products.
Arzeda and Takeda Collaborate to Use AI-Driven Protein Design to Optimize Therapeutic Biologics
Arzeda will collaborate with Takeda to apply its AI-driven Intelligent Protein Design Technology™ to optimize therapeutic proteins in Takeda’s biologics research pipeline. The partnership aims to use computational design and machine-learning to accelerate protein optimization for potential incorporation into therapeutic products.
Arzeda launches ProSweet Enzymes™ to cost-effectively produce high-purity Reb D and Reb M from stevia leaf extract
Arzeda has launched ProSweet Enzymes™ that enable sweetener companies to produce high-purity Reb D and Reb M directly and cost-effectively from stevia leaf extract, expanding its enzymatic stevia solutions and commercial partnerships.
Arzeda Featured in Nature Biotechnology for AI-Enhanced Design of Proteins That Never Existed
Arzeda is highlighted in Nature Biotechnology for using AI-enhanced computational tools to design novel proteins that have never existed in nature.
Arzeda and AAK Partner to Use AI Protein Design and Novel Enzymes to Create More Sustainable Plant-Based Oils
Arzeda and AAK signed a joint development agreement to use Arzeda’s protein design platform and novel enzymes to develop more sustainable, efficient plant-based specialty oils and fats for the food industry. The collaboration aims to optimize proteins with computational design and AI to improve sustainability profiles and production efficiencies for AAK’s edible oils.
Arzeda and W. L. Gore & Associates Partner to Develop Sustainable High-Performance Materials Using Computationally Designed Proteins
Arzeda is collaborating with W. L. Gore & Associates to research how computationally designed proteins can create new, high-performance, and more sustainable materials. The partnership aims to leverage Arzeda’s protein-design platform and Gore’s materials expertise to improve material performance while reducing waste and resource intensity.
Arzeda Hires Ken Barrett as CBO and Scott Fabro as SVP Food Ingredients to Commercialize Enzyme Portfolio after $33M Series B
Arzeda hired Ken Barrett as Chief Business Officer and Scott Fabro as Senior Vice President of Food Ingredients to drive commercialization and product revenue for its computer-designed enzyme portfolio. The company, fresh off a $33M Series B, aims to commercialize enzymes for consumer personal care, home products, and food through partnerships with leading CPG firms.
Arzeda Raises $33M Series B Led by Conti Ventures to Commercialize Computer-Designed Enzymes
Arzeda raised $33 million in a Series B led by Conti Ventures with participation from Lewis & Clark Agrifood, Bunge Ventures, Circulate Capital, and returning investors to accelerate commercialization of computer-designed enzymes for food, home care, chemicals, and other sectors.
Unilever announces three-year partnership with Arzeda to use AI-designed enzymes in OMO, Sunlight and Surf
Unilever has begun a three-year strategic partnership with Arzeda to use computational and AI-driven enzyme design to improve sustainability and performance across its cleaning and laundry brands, supporting its goal to remove virgin fossil-fuel feedstocks from formulations.
Codexis and Casdin Capital Co-Invest in Arzeda via SynBio Innovation Accelerator, Forming Collaboration Plans
Codexis and Casdin Capital co-invested in Arzeda through the SynBio Innovation Accelerator, and Codexis and Arzeda plan to collaborate on synergistic projects moving forward.
Arzeda Appoints Doug Cameron to Board as It Targets Commercial Deployment of Designer Enzymes for Food & Nutrition
Arzeda is expanding its protein design platform into sustainable food and nutrition ingredients and has appointed biotechnology veteran Doug Cameron, PhD, to its board to support commercial deployment of designer enzymes for products like natural sweeteners, soluble fibers, structured lipids, plant-based proteins, and cannabinoids.
Arzeda and Amyris sign second collaboration for computationally designed enzymes with milestone funding and commercialization value share
Arzeda and Amyris signed a second development collaboration to have Arzeda design novel, computationally engineered enzymes for Amyris’s fermentation processes to produce high‑value ingredients, with milestone-based payments, an early-success bonus, and a commercialization value share.
People
See all 5-
Alex Zanghelini Co-founder
-
Alexandre Zanghellini Executive Officer, Director, Promoter, Co-founder and PhD — Co-Founder & Chief Executive Officer
-
Ken Barrett Executive, MBA, MS — Chief Business Officer